Mule Theiler’s Disease: Acute Serum Hepatitis and Liver Failure
- See your vet immediately if your mule seems depressed, stops eating, develops jaundice, acts neurologic, or becomes weak after receiving tetanus antitoxin, plasma, or another equine-origin biologic within the past 4 to 13 weeks.
- Theiler’s disease, also called acute serum hepatitis, is an acute liver failure syndrome recognized in equids and strongly associated with equine parvovirus-hepatitis and prior exposure to equine serum products.
- Common warning signs include lethargy, poor appetite, jaundice, photosensitivity, behavior changes, head pressing, aimless wandering, and other signs of hepatic encephalopathy.
- Diagnosis usually involves urgent bloodwork, bile acids or ammonia testing, and often ultrasound; your vet may also recommend liver biopsy and PCR testing for equine parvovirus-hepatitis when available.
- Typical 2025-2026 US cost range for initial workup and treatment is about $600-$1,800 for field evaluation and basic testing, $1,500-$4,000 for intensive medical management, and $4,000-$10,000+ for hospitalization and critical care.
What Is Mule Theiler’s Disease?
Mule Theiler’s disease is an acute hepatitis syndrome that can progress to liver failure very quickly. In equids, it has historically been called serum hepatitis because many cases develop weeks after exposure to equine-origin biologic products, especially tetanus antitoxin, plasma, or other serum-derived products. More recent research strongly links many cases to equine parvovirus-hepatitis (EqPV-H).
Although most published information is in horses, the same liver disease principles apply to mules because they are equids and can receive the same biologic products. The liver helps process nutrients, clear toxins, and support normal brain function. When the liver suddenly fails, toxins can build up in the bloodstream and affect the brain, causing hepatic encephalopathy, which is why some affected mules become dull, disoriented, or unsafe to handle.
This condition is always urgent. Some mules show only vague early signs like reduced appetite and quiet behavior. Others decline fast and develop jaundice, neurologic signs, or collapse. Early veterinary care gives your mule the best chance for stabilization while the liver tries to recover.
Symptoms of Mule Theiler’s Disease
- Sudden lethargy or marked depression
- Poor appetite or complete refusal to eat
- Jaundice (yellow gums, eyes, or skin)
- Photosensitivity or sunburn-like skin irritation on light-colored areas
- Behavior changes, dullness, or seeming "not right"
- Head pressing, circling, aimless wandering, or stumbling
- Weakness or recumbency
- Colic-like discomfort
- Dark urine
- Fever is variable or absent
See your vet immediately if your mule has jaundice, neurologic signs, severe weakness, or sudden illness after receiving tetanus antitoxin, plasma, or another equine-origin biologic in the past 1 to 3 months. Clinical signs in equids often appear about 4 to 10 weeks after exposure, though some guidance notes a window up to 13 weeks.
Neurologic changes matter most because they can mean toxins are affecting the brain. A mule with hepatic encephalopathy may become unpredictable, unsafe to transport, or unable to stay standing. Keep the environment quiet, reduce stress, and wait for your vet’s instructions.
What Causes Mule Theiler’s Disease?
The classic trigger is exposure to an equine-origin biologic product. Historically reported products include tetanus antitoxin, equine plasma, and other serum-derived antitoxins or antisera. In many equine cases, illness begins weeks after administration, not right away, which can make the connection easy to miss.
Current evidence strongly associates Theiler’s disease with equine parvovirus-hepatitis (EqPV-H). This virus has been detected in many affected equids and in some commercial equine serum pools. Because of that risk, regulatory and industry testing of equine serum and plasma products has increased in recent years. Even so, no preventive strategy removes risk completely.
Not every mule exposed to a biologic will get sick, and not every case has a clearly documented product exposure. Researchers suspect that individual immune response, viral dose, and other liver stressors may influence whether an equid develops severe hepatitis. Your vet may also consider other causes of acute liver disease, including toxic plants, other hepatotoxins, infectious disease, and less common metabolic or biliary problems.
How Is Mule Theiler’s Disease Diagnosed?
Diagnosis starts with a careful history and urgent bloodwork. Tell your vet about any tetanus antitoxin, plasma transfusion, serum product, wound treatment, or biologic injection in the previous 4 to 13 weeks. Blood tests often show marked liver injury, and your vet may check enzymes, bilirubin, glucose, clotting status, bile acids, and sometimes ammonia, depending on what is available.
Your vet may also recommend abdominal ultrasound to assess the liver and rule out other problems. In some cases, liver biopsy is the best way to confirm the type and extent of injury, especially if the diagnosis is uncertain or if long-term planning depends on knowing how much viable liver tissue remains.
If available, your vet may submit PCR testing for EqPV-H on blood or tissue. A positive result can support the diagnosis, but your vet still has to interpret it alongside the exam, timing, and lab findings. Because mules with liver failure can become neurologic and medically fragile, diagnosis and stabilization often happen at the same time.
Treatment Options for Mule Theiler’s Disease
Spectrum of Care means you have options. Here are treatment tiers at different price points.
Budget-Conscious Care
- Urgent farm call or clinic exam
- CBC and chemistry panel focused on liver values
- Basic supportive care directed by your vet
- Oral or enteral nutritional support if safe
- Quiet housing, shade, and reduced stress
- Monitoring for neurologic changes and hydration status
- Referral discussion if the mule worsens
Recommended Standard Treatment
- Hospital or day-hospital monitoring as needed
- Serial bloodwork to track liver injury and glucose
- IV fluids with electrolyte and dextrose support when indicated
- Medical management for hepatic encephalopathy as directed by your vet
- Anti-inflammatory or antimicrobial decisions based on exam and lab findings
- Diet planning to support energy intake while limiting complications
- Ultrasound and additional liver function testing
Advanced / Critical Care
- Referral hospital admission and intensive monitoring
- Repeated chemistry, coagulation, glucose, and ammonia assessment
- Continuous IV fluid and dextrose support when needed
- Aggressive management of hepatic encephalopathy and recumbency risks
- Liver biopsy or advanced diagnostics when safe
- Blood products or additional procedures if complications develop
- Longer hospitalization and structured recheck plan after discharge
Cost estimates as of 2026-03. Actual costs vary by location, clinic, and individual case.
Questions to Ask Your Vet About Mule Theiler’s Disease
Bring these questions to your vet appointment to get the most out of your visit.
- You can ask your vet whether my mule’s recent tetanus antitoxin, plasma, or other biologic exposure fits the timing for Theiler’s disease.
- You can ask your vet which blood tests best show how severe the liver injury is right now.
- You can ask your vet whether my mule has signs of hepatic encephalopathy and what safety steps we should take during handling and transport.
- You can ask your vet if hospitalization is recommended now or if monitored farm care is still reasonable.
- You can ask your vet whether ultrasound, bile acids, ammonia testing, or liver biopsy would change treatment decisions.
- You can ask your vet if EqPV-H PCR testing is available and whether it would be useful in this case.
- You can ask your vet what feeding plan is safest while the liver is recovering.
- You can ask your vet what warning signs mean my mule needs immediate recheck, even after starting treatment.
How to Prevent Mule Theiler’s Disease
Prevention focuses on reducing avoidable exposure to equine serum products. One practical step is keeping your mule current on tetanus vaccination, because that may reduce the chance your vet will need to use tetanus antitoxin after a wound. Antitoxin can still be appropriate in some situations, but it should be a thoughtful risk-benefit discussion with your vet.
If your mule needs plasma, antitoxin, or another biologic, ask your vet about the product source, current safety screening, and whether there are non-serum alternatives for the specific problem. In the United States, oversight and testing of licensed equine serum and plasma products have increased because of the recognized link between these products and EqPV-H-associated hepatitis.
There is no vaccine for EqPV-H at this time. Good prevention also means avoiding unnecessary injections, keeping accurate medical records, and watching closely for reduced appetite, jaundice, or behavior changes for up to 13 weeks after biologic exposure. Fast recognition does not prevent the disease, but it can shorten the time to treatment.